Relevant issues to biossimilars licensing
When the patent of a drug expires, low cost generics may be introduced in market. Trial results that demonstrate the safety and efficacy of the reference product can be extrapolated to the generic, simplifying the approval process. This paradigm cannot be applied to biopharmaceutical products, large...
Saved in:
Published in | Revista brasileira de epidemiologia Vol. 15; no. 4; p. 748 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Brazil
01.12.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!